Hematologic Tests

Known as: Hematologic Test, hematologic testing, Tests, Blood 
A laboratory test to measure hematopoietic components and investigate hematologic disorders in a blood sample.
National Institutes of Health

Related topics

Related topics

30 relations
Alpha one fetoprotein measurementAmino acids measurementBlood Physiological PhenomenaBlood glucose measurement
(More)

Broader (2)

BloodHematological Disease

Narrower (13)

Blood Cell CountBlood Chemical AnalysisBlood Chemistry MeasurementBlood Grouping and Crossmatching
(More)

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Periodontal therapy for the management of cardiovascular disease in patients with chronic periodontitis.
BACKGROUND There is an association between chronic periodontitis and cardiovascular disease (CVD). However, it is not known… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 2
Is this relevant?
Review
2017
Review
2017
Blood-based NfL A biomarker for differential diagnosis of parkinsonian disorder
Objective: To determine if blood neurofilament light chain (NfL) protein can discriminate between Parkinson disease (PD) and… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Clinical and biomarker changes in dominantly inherited Alzheimer's disease.
BACKGROUND The order and magnitude of pathologic processes in Alzheimer's disease are not well understood, partly because the… (More)
  • table 1
  • table 2
  • table 2
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers
Glioblastoma tumour cells release microvesicles (exosomes) containing mRNA, miRNA and angiogenic proteins. These microvesicles… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2006
Review
2006
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Better biomarkers are urgently needed to improve diagnosis, guide molecularly targeted therapy and monitor activity and… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence.
We have updated guidelines for screening for colorectal cancer. The original guidelines were prepared by a panel convened by the… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Updated definitions of healthy ranges for serum alanine aminotransferase levels.
Context Current upper limits (500 nkat/L [30 U/L] for women, 667 nkat/L [40 U/L] for men) for serum alanine aminotransferase (ALT… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.
BACKGROUND Methods of classifying chronic obstructive pulmonary disease (COPD) depend largely upon spirometric measurements but… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Randomised study of screening for colorectal cancer with faecal-occult-blood test
BACKGROUND Case-control studies and a voluntary-based follow-up study have suggested that repeated screening with faecal-occult… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.
BACKGROUND Although tests for occult blood in the feces are widely used to screen for colorectal cancers, there is no conclusive… (More)
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?